Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2656–2670 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5771 TYK2 Gene Tyrosine Kinase 2 Deficiency Genetic Test This genetic test identifies pathogenic variants in the TYK2 gene associated with primary immunodeficiencies like autosomal recessive hyper-IgE syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TYK2 gene", "Deletion/duplication analysis of the TYK2 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Document all current medications"] Indications ["Suspected autosomal recessive hyper-IgE syndrome", "Evaluation of primary immunodeficiency", "Family history of TYK2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 101246-5 ICD-10: D82.4 Clinical summary This genetic test identifies pathogenic variants in the TYK2 gene associated with primary immunodeficiencies like autosomal recessive hyper-IgE syndrome.
TEST-5218 TYMP Gene MNGIE Syndrome (Without Leukoencephalopathy) Genetic Test This genetic test identifies mutations in the TYMP gene associated with MNGIE syndrome without leukoencephalopathy.	Whole Blood (EDTA tube), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the TYMP gene", "Full TYMP gene sequencing (all exons & splice sites)"] Parameters [] Preparation ["No fasting required", "No medication adjustment required", "Carry relevant medical reports and previous neurological investigations"] Indications ["Suspected MNGIE syndrome", "Family history of MNGIE syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81305-3 ICD-10: E88.49 Clinical summary This genetic test identifies mutations in the TYMP gene associated with MNGIE syndrome without leukoencephalopathy.
TEST-5425 TYR Gene (Oculocutaneous Albinism Type 1B) Genetic Test This genetic test analyzes the TYR gene to identify mutations causing Oculocutaneous Albinism Type 1B (OCA1B). It provides a definitive molecular diagnosis for this specific type o...	Peripheral whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the TYR gene", "Single-nucleotide variants (SNVs)", "Small indels"] Parameters [{"name": "Gene Coverage", "reference_range": "Full TYR coding region + 20 bp intronic flanks"}, {"name": "Sensitivity", "reference_range": ">99.9% for single‑nucleotide variants & small indels"}] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session", "Clinical history form submission prior to collection"] Indications ["Suspected diagnosis of Oculocutaneous Albinism Type 1B (OCA1B)", "Differentiation from other hypopigmentation disorders", "Family planning and prenatal diagnosis", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 64652-5 ICD-10: E70.319 Clinical summary This genetic test analyzes the TYR gene to identify mutations causing Oculocutaneous Albinism Type 1B (OCA1B). It provides a definitive molecular diagnosis for this specific type of albinism.
TEST-3470 TYR Gene Albinism Oculocutaneous Type 1B Genetic Test This genetic test evaluates the TYR gene for pathogenic variants associated with Oculocutaneous Albinism Type 1B.	Whole blood (2 mL EDTA), extracted DNA, or blood spot on FTA card	3–4 Weeks (expedited if clinically urgent)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TYR gene", "Tyrosinase gene sequence"] Parameters [] Preparation ["No fasting required"] Indications ["Diagnosis of Oculocutaneous Albinism Type 1B", "Carrier detection", "Personalized management"] Measurement technique Confirm with laboratory Codes LOINC: 21636-2 ICD-10: E70.31 Clinical summary This genetic test evaluates the TYR gene for pathogenic variants associated with Oculocutaneous Albinism Type 1B.
TEST-3488 TYR Gene Genetic Test for Oculocutaneous Albinism Type 1A This genetic test identifies pathogenic variants within the TYR gene associated with oculocutaneous albinism type 1A.	Whole Blood, Extracted DNA, or One-drop Blood on FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TYR gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomy team if on anticoagulants (e.g., warfarin, clopidogrel)"] Indications ["Suspected diagnosis of oculocutaneous albinism type 1A", "Family history of albinism", "Need for definitive genetic diagnosis for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 48004-8 ICD-10: E70.30 Clinical summary This genetic test identifies pathogenic variants within the TYR gene associated with oculocutaneous albinism type 1A.
TEST-5421 TYRP1 Gene Albinism, Oculocutaneous Type 3 (OCA3) Genetic Test This test identifies pathogenic variants in the TYRP1 gene associated with oculocutaneous albinism type 3 (OCA3). It utilizes next-generation sequencing (NGS) for comprehensive ana...	Peripheral Whole Blood (EDTA) or Buccal Swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TYRP1 gene sequence", "Copy number variants in TYRP1"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any bleeding disorders"] Indications ["Suspected diagnosis of oculocutaneous albinism type 3 (OCA3)", "Family cascade testing for OCA3", "Reproductive planning for families with OCA3"] Measurement technique Confirm with laboratory Codes LOINC: 94853-9 ICD-10: E70.330 Clinical summary This test identifies pathogenic variants in the TYRP1 gene associated with oculocutaneous albinism type 3 (OCA3). It utilizes next-generation sequencing (NGS) for comprehensive analysis.
TEST-3473 TYRP1 Oculocutaneous Albinism Type 3 (OCA3) Genetic Test This genetic test evaluates the TYRP1 gene for pathogenic variants associated with oculocutaneous albinism type 3 (OCA3). It helps confirm the diagnosis in individuals with suspect...	Peripheral whole blood	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TYRP1 gene"] Parameters [] Preparation [] Indications ["Individuals presenting with fair skin, light hair, nystagmus, reduced visual acuity", "Family history suggestive of autosomal recessive albinism"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E70.32 Clinical summary This genetic test evaluates the TYRP1 gene for pathogenic variants associated with oculocutaneous albinism type 3 (OCA3). It helps confirm the diagnosis in individuals with suspected OCA3.
TEST-3833 UBE3A (15q11) Gene Angelman Syndrome Genetic Test This test evaluates the UBE3A gene for mutations, deletions, or imprinting defects associated with Angelman syndrome.	Whole blood (EDTA tube), extracted genomic DNA, or dried blood spot on an FTA card	21–28 calendar days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UBE3A gene sequence", "Methylation patterns"] Parameters [] Preparation [] Indications ["Suspected Angelman syndrome based on clinical features", "Developmental delay with specific neurological signs"] Measurement technique Confirm with laboratory Codes LOINC: 61896-3 ICD-10: Q93.5 Clinical summary This test evaluates the UBE3A gene for mutations, deletions, or imprinting defects associated with Angelman syndrome.
TEST-3515 UBE3B Gene Blepharophimosis-Ptosis-Intellectual Disability Syndrome Genetic Test This test identifies pathogenic variants within the UBE3B gene associated with Blepharophimosis-Ptosis-Intellectual Disability syndrome (BPID). It uses Next Generation Sequencing (...	Peripheral whole blood (EDTA), FTA card, or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [{"name": "UBE3B Gene Coverage", "reference_range": "100% coverage"}, {"name": "Mean Depth of Coverage", "reference_range": ">200x"}] Preparation ["No specific fasting required.", "No medication or diet restrictions."] Indications ["Suspected Blepharophimosis-Ptosis-Intellectual Disability syndrome (BPID)", "Congenital eye malformations with developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 92807-8 ICD-10: Q87.89, Q10.3 Clinical summary This test identifies pathogenic variants within the UBE3B gene associated with Blepharophimosis-Ptosis-Intellectual Disability syndrome (BPID). It uses Next Generation Sequencing (NGS) to analyze the gene's coding regions and flanking introns.
TEST-3804 UBQLN2 Gene Analysis (Amyotrophic Lateral Sclerosis, X-Linked Juvenile & Adult-Onset) Genetic Test This genetic test identifies pathogenic variants in the UBQLN2 gene, which are associated with specific forms of amyotrophic lateral sclerosis (ALS). It helps confirm a diagnosis a...	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UBQLN2 gene sequence", "Pathogenic variants in UBQLN2"] Parameters [] Preparation [] Indications ["Clinical suspicion of X-linked amyotrophic lateral sclerosis (ALS)", "Definitive molecular diagnosis for prognosis and family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81265-2 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic variants in the UBQLN2 gene, which are associated with specific forms of amyotrophic lateral sclerosis (ALS). It helps confirm a diagnosis and assess familial risk.
TEST-3677 UBR1 Gene Johanson‑Blizzard Syndrome Genetic Test This genetic test identifies pathogenic variants in the UBR1 gene associated with Johanson-Blizzard syndrome.	Peripheral blood or Buccal swab (FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UBR1 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected Johanson-Blizzard syndrome", "Patients with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 21634-6 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the UBR1 gene associated with Johanson-Blizzard syndrome.
TEST-6174 UCP2 Gene Hyperinsulinism (UCP2-Related) Genetic Test This genetic test identifies mutations within the UCP2 gene associated with congenital hyperinsulinism.	Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UCP2 gene mutations", "Congenital hyperinsulinism genetic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of congenital hyperinsulinism", "Identification of UCP2 gene mutations", "Genetic counseling for families with hyperinsulinism"] Measurement technique Confirm with laboratory Codes LOINC: 82386-1 ICD-10: P70.1 Clinical summary This genetic test identifies mutations within the UCP2 gene associated with congenital hyperinsulinism.
TEST-3905 UGT1A1 Gene Crigler-Najjar Syndrome Type 2 Genetic Test This genetic test identifies pathogenic variants in the UGT1A1 gene associated with Crigler-Najjar syndrome type 2.	Whole Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UGT1A1 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No fasting or dietary preparation required"] Indications ["Diagnostic confirmation of Crigler-Najjar syndrome type 2", "Carrier screening", "Pharmacogenomic guidance"] Measurement technique Confirm with laboratory Codes LOINC: 81289-2 ICD-10: E80.5, Z13.228, Z31.5 Clinical summary This genetic test identifies pathogenic variants in the UGT1A1 gene associated with Crigler-Najjar syndrome type 2.
TEST-3369 UGT1A1 Gene Polymorphism (TA Repeat) Detection Test This test evaluates the number of TA repeats in the UGT1A1 gene promoter, identifying genetic variations associated with drug metabolism and bilirubin clearance.	Peripheral Whole Blood (EDTA)	7 Working Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Number of TA dinucleotide repeats in the UGT1A1 gene promoter", "UGT1A1 gene alleles (e.g., (TA)6, (TA)7)"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Provide a 4 mL whole blood sample in an EDTA tube", "Keep sample refrigerated but never frozen"] Indications ["Predicting severe irinotecan toxicity", "Confirming Gilbert syndrome", "Personalized chemotherapy dosing"] Measurement technique Confirm with laboratory Codes LOINC: 21622-0 ICD-10: Z13.89 Clinical summary This test evaluates the number of TA repeats in the UGT1A1 gene promoter, identifying genetic variations associated with drug metabolism and bilirubin clearance.
TEST-5698 ULK2 Gene (Smith-Magenis Syndrome) Genetic Test This test identifies pathogenic variants in the ULK2 gene associated with Smith-Magenis syndrome.	Peripheral Whole Blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ULK2 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No special preparation required", "Stay hydrated", "Wear comfortable clothing"] Indications ["Suspected Smith-Magenis syndrome", "Developmental delay with characteristic features", "Family history of SMS"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q93.89, Q87.8 Clinical summary This test identifies pathogenic variants in the ULK2 gene associated with Smith-Magenis syndrome.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories